Dapagliflozin Impact on the Exercise Capacity of Non-Diabetic Heart Failure with Reduced Ejection Fraction Patients

Autor: Reis, J, Teixeira, AR, Valentim Gonçalves, A, Ilhão Moreira, R, Pereira da Silva, T, Timóteo, AT, Cruz Ferreira, R
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Popis: Background: Dapagliflozin has been shown to reduce morbidity and mortality in Heart Failure with reduced Ejection Fraction (HFrEF), but its impact on exercise capacity of non-diabetic HF outpatients is unknown. Methods: Adult non-diabetic HF patients with a left ventricular ejection fraction (LVEF)
Databáze: OpenAIRE